MAP2K7 and cancer: This activation induces phosphorylation of effectors of the mitogen-activated protein kinase (MAPK) pathway like RAF, MEK, and ERK leading to apoptosis inhibition and activation of transcription factors that promote cancer cell survival and metastasis (3, 4).